Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA.
Walter P MaksymowychOliver M FitzGeraldMikkel ØstergaardJoanne HomikDésirée Mfm van der HeijdeRobert G W LambertOri ElkayamJosef S SmolenJ Carter ThroneMaggie J LarchéGianfranco FerraccioliMarina BackhausGerd-Rüdiger R BurmesterGilles BoireBernard CombeThierry SchaeverbekeAlain SarauxMaxime DougadosMaurizio RossiniMarcello GovoniLuigi SinigagliaAlain CantagrelCheryl C M BarnabeClifton O BinghamPaul P TakDirkjan van SchaardenburgHilde Berner HammerJoel PaschkeRana DadashovaEdna HutchingsAlexandre SeprianoRobert LandewéPublished in: The Journal of rheumatology (2019)
The RA BIODAM prospective study succeeded in generating an extensive list of clinical, imaging (2343 radiographs), and biosample (4638 sera) resources that will be made available to expedite the identification and validation of biomarkers for radiographic damage endpoints. (Clinicaltrials.gov: NCT01476956, clinicaltrials.gov/ct2/show/NCT01476956).
Keyphrases
- rheumatoid arthritis
- disease activity
- ankylosing spondylitis
- interstitial lung disease
- systemic lupus erythematosus
- high resolution
- computed tomography
- oxidative stress
- image quality
- contrast enhanced
- type diabetes
- dual energy
- idiopathic pulmonary fibrosis
- adipose tissue
- fluorescence imaging
- skeletal muscle
- glycemic control